Competition & Peer Data API & CSV Delivery Connect to AI Assistant via MCP

Minimed Group Inc's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Minimed Group Inc (MMED) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q1 2026
Competitors Tracked
-
Publicly traded peers
Peer Group Market Share
100.00 %
Share of combined sales, Q1 2026
Revenue Growth Y/Y
-
Q1 2026
Net Margin
0.00 %
Q1 2026

Key Findings: Minimed Group Inc vs Its Competitors

  • Scale: Minimed Group Inc ranks #34 of 163 companies by market capitalization in the Cloud Computing & Data Analytics industry, holding 0.6% of industry market cap.
  • Peer revenue share: Minimed Group Inc accounted for 100.0% of combined revenue among its tracked peer group.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

MMED Sales vs. its Competitors, Q1 2026

Minimed Group Inc generated 100.00 % of the combined sales of its peer group.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/MMED/competitors
https://api.csimarket.com/api/v1/companies/MMED/relationships
https://api.csimarket.com/api/v1/companies/MMED/similar
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API

Minimed Group Inc's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
Minimed Group Inc - - - Yes
High-Confidence Competitors (62) 51% 73% 61% 36%
Similar-Size Competitors (10) 88% 60% 50% 10%

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

Market Share of the Peer Group, Q1 2026

100%market share
  • Minimed Group Inc100.0%
  • Competitors combined0.0%

Share of combined quarterly revenue of Minimed Group Inc and its 0 tracked competitors.

See Minimed Group Inc's full market share breakdown »

MMED Stock Performance relative to its Competitors

MMED Competitors (weighted) Percent change over the selected range

Minimed Group Inc's Share Price Performance vs Peer Groups

Trailing 12-month total share price return, and the share of each group that outperformed the U.S.A. 500 over the same period. Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC.
38.8%beat U.S.A. 500
High-Confidence
(19 of 49)
20%beat U.S.A. 500
Similar-Size
(2 of 10)
Entity TTM Share Price Return
(group: median)
vs U.S.A. 500
Minimed Group Inc - -
Competitors combined (0) 40.4% 63.2%
High-Confidence Competitors (49) 40.4% 63.2%
Similar-Size Competitors (10) 40.4% 63.2%
Similar Growth & Profitability (0) 40.4% 63.2%
Peer Group Share Price Returns

TTM share price return and U.S.A. 500 outperformance for Minimed Group Inc's competitor groups requires a Commercial License.

Source: CSIMarket API (daily market-structure computation). Outperformance is trailing-12-month total return vs the U.S.A. 500 over the same window, not risk-adjusted.

MMED Stock Performance relative to High-Confidence Competitors

MMED High-Confidence Competitors (equal-weighted, 64) Percent change over the selected range

MMED Stock Performance relative to Similar-Size Competitors

MMED Similar-Size Competitors (equal-weighted, 10) Percent change over the selected range

Minimed Group Inc's Comment on Competition and Industry Peers

The company offers an integrated Smart Dosing ecosystem comprising smart insulin pumps, continuous glucose monitors (CGMs), consumables, the SmartGuard algorithm, dosing software, and smart pens. This approach contrasts with competitors who typically provide component and subsystem solutions, such as standalone CGM sensors, pumps, or dosing software, often partnering to deliver automated insulin delivery (AID) solutions compatible across different technologies rather than a fully integrated system. The company serves pump users in over 80 countries and has produced over five million insulin pumps since 2001. The competitive environment features rapid technological advancements, extensive intellectual property protections, the necessity of scale for profitability, and the importance of customer service and support. Competitors’ fragmented ecosystems may cause user confusion, whereas the company provides a single point of contact through its integrated system. The company has an agreement with Abbott to purchase certain Abbott CGMs and has agreed not to purchase, market, or distribute CGMs from specified Abbott competitors. Medtronic is involved in arrangements with Blackstone Life Sciences Advisors L.L.C. concerning funding for diabetes product development. Competitors identified include Abbott, Blackstone Life Sciences Advisors L.L.C., and Medtronic.

Minimed Group Inc's Competitors Named by the Company

Competitive relationships identified from Minimed Group Inc reports and corroborating sources, each with a basis and confidence.
Competitor Basis Confidence Active Sources
Angiodynamics Inc Company report 85% 2022 to 2026 3
Intuitive Surgical Inc Company report 85% 2022 to 2026 3
Neuroone Medical Technologies Corp Company report 85% 2022 to 2026 3
Edwards Lifesciences Corporation Company report 85% 2022 to 2026 3
Senseonics Holdings Inc Company report 85% 2022 to 2026 3
Sintx Technologies Inc Company report 85% 2022 to 2026 3
Neuropace Inc Company report 85% 2022 to 2026 3
Orchestra Biomed Holdings Inc Company report 85% 2022 to 2026 3
Bone Biologics Corporation Company report 85% 2022 to 2026 3
Pulse Biosciences Inc Company report 85% 2022 to 2026 3
Si bone inc Company report 85% 2022 to 2026 3
Ss Innovations International Inc Company report 85% 2022 to 2026 3
Penumbra Inc Company report 85% 2022 to 2026 3
Bioventus Inc Company report 85% 2022 to 2026 3
Catheter Precision Inc Company report 85% 2022 to 2026 3
Inspiremd Inc Company report 85% 2022 to 2026 3
Atricure Inc Company report 85% 2022 to 2026 3
Insulet Corporation Company report 85% 2022 to 2026 3
Encision Inc Company report 85% 2022 to 2026 3
Sharps Technology Inc Company report 85% 2022 to 2026 3
Usbc Inc Company report 85% 2022 to 2026 3
Integra Lifesciences Holdings Corp Company report 85% 2022 to 2026 3
Streamex Corp Company report 85% 2022 to 2026 3
Autonomix Medical Inc Company report 85% 2022 to 2026 3
Movano Inc Company report 85% 2022 to 2026 3
Avinger Inc Company report 85% 2022 to 2026 3
Acutus Medical Inc Company report 85% 2022 to 2026 3
Shockwave Medical Inc Company report 85% 2022 to 2026 3
Electromedical Technologies Inc Company report 85% 2022 to 2026 3
Motus Gi Holdings Inc Company report 85% 2022 to 2026 3
Modular Medical Inc Company report 85% 2022 to 2026 3
Abbott Laboratories Company report 85% 2022 to 2026 3
Glucotrack Inc Company report 85% 2022 to 2026 3
Blackstone Life Sciences Advisors L.L.C. Company report 85% 2022 to 2026 3
Stryker Corp Company report 85% 2022 to 2026 3
Avanos Medical Inc Company report 85% 2022 to 2026 3
Koninklijke Philips Nv Company report 85% 2022 to 2026 3
Nuwellis Inc Company report 85% 2022 to 2026 3
Globus Medical Inc Company report 85% 2022 to 2026 3
Capsovision Inc Company report 85% 2022 to 2026 3
Competitor Evidence Detail

Company report basis, confidence, active dates and source counts for Minimed Group Inc's named competitors require a Commercial License.

Methodology: relationships are extracted from Minimed Group Inc reports (named-competitor disclosures) and corroborating sources. Confidence reflects evidence strength.

Get the full CSIMarket dataset: Subscribe API Connect Your AI